![Rami Komrokji: Our paper addressing pattern of lower risk myelodysplastic syndrome progression](https://oncodaily.com/pub/uploads/2023/09/743C9044-8493-411A-A850-C7D375BB3DB2-e1694981916814-1280x1056.jpeg)
Photo from Rami Komrokji/Twitter
Feb 9, 2024, 05:19
Rami Komrokji: Our paper addressing pattern of lower risk myelodysplastic syndrome progression
Quoting Rami Komrokji, Vice Chair of the Malignant Hematology Department at Moffitt Cancer Centre and Research Institute, on X/Twitter:
”Early View / Hematologica our paper addressing pattern of LRMDS progression. Majority don’t progress and molecular signatures can identify direct AML progression.”
Source: Rami Komrokji/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 11, 2024, 11:11
Sep 11, 2024, 10:55
Sep 11, 2024, 10:52
Sep 11, 2024, 09:23
Sep 11, 2024, 09:14
Sep 11, 2024, 09:12